Shree Pushkar Chemicals & Fertilizers Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 15 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.2K Cr

FY25 revenue expected to exceed Rs. Revenue growth target for FY26 is around 25%, aiming for approximately Rs.

From Shree Pushkar Chemicals & Fertilizers Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

401

Market Cap

₹1.2K Cr

P/E Ratio

17.2

How does Shree Pushkar Chemicals & Fertilizers Ltd rank in Chemicals & Petrochemicals?

Compare Shree Pushkar Chemicals & Fertilizers Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Shree Pushkar Chemicals & Fertilizers Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹13 Cr.

Full financials →

📊 Revenue & Sales Performance

  • FY25 revenue expected to exceed Rs. 800 crores, with strong Q3 performance of Rs. 586 crores and Rs. 214 crores remaining.
  • FY26 revenue growth target around 25%, aiming for Rs. 1,000 crores driven by expansion projects (Unit 5 starting April 2025, Unit 6 near completion by Diwali 2025).
  • Fertilizer volumes expected to improve with full-year production from new fertilizer plant (approx. 1500 tons capacity).
  • Chemical division has potential to increase utilization by 15-20% from current 50-55%.
  • EBITDA and PAT margins expected to improve gradually, with EBITDA margin hopeful to rise beyond current 10.3%, and PAT margins targeting 8-8.5% range.
  • Demand is supported by import dynamics, government initiatives (BIS certification), and market conditions such as decreased Chinese imports.
  • Ongoing CAPEX investments funded internally to drive capacity and efficiency improvements.

📈 Profitability & Margins

  • Revenue growth target for FY26 is around 25%, aiming for approximately Rs. 1,000 crores.
  • PAT margin guidance for FY26 is around 8%-8.5%, up from about 7.5% currently.
  • EBITDA margins have improved to about 10.3% in Q3FY25 with an expectation of further improvement in the coming times, though no exact FY26 margin figure given yet.
  • Conservative guidance is maintained; management prefers to give cautious projections with visibility improving towards the end of Q4FY25.
  • Expansion in Unit 5 starting April 2025 and Unit 6 near completion by Diwali 2025 expected to drive growth.
  • Management confident about achieving Rs. 800 crores+ revenue in FY25, with strong visibility for further growth.
  • Despite recent disruptions (fire shutdown), company expects solid earnings growth supported by capacity ramps and operational efficiencies.

🏗️ Capital Expenditure Plans

  • The company has invested Rs. 84.9 crores in CAPEX during FY2025 (up to December 31, 2024), funded entirely through internal accruals.
  • Ongoing CAPEX work includes expansions at Unit 5 (starting April 2025) and Unit 6 (expected completion around Diwali 2025).
  • Solar power project of 3.8 MW has been completed and started.
  • MVPL-related works are almost completed.
  • A planned caustic soda plant (50 TPD) project producing caustic and chlorine is under consideration but is likely to be scrapped.
  • If scrapped, the company will save approx. Rs. 85 crores from the Rs. 146 crores loan/investment planned.
  • Trial production for current expansions expected by Diwali 2025, commercial production by December 2025.
  • Strategic move includes approval of merger of two wholly-owned subsidiaries to optimize operations and resources.

💰 Fundraising & Capital Structure

  • The company has a no-lien deposit facility of Rs. 146.19 crore as of December 31, 2024, providing strong liquidity and financial flexibility.
  • Rs. 146 crore loans and investments are still left for ongoing CAPEX, but Rs. 85 crore has already been invested.
  • The company expects no need to approach banks for additional funding as Rs. 146 crore is available (Page 7).
  • CAPEX is funded through internal accruals; no mention of new equity or external debt fundraising.
  • Management is cautious and prefers conservative financial management without overleveraging.
  • No indication of plans for future fundraising through debt or equity in the near term.

📋 Order Book & Pipeline

  • The company books orders for 1 to 1.5 months in advance; they do not take longer-term orders beyond this period.
  • As of mid-February 2025, the order book visibility is strong, with bookings made until the end of March 2025.
  • The management sees a clear visibility of around INR 800 crores in revenue by March for Q4 FY25.
  • The company prefers to manage orders on a quarterly basis rather than through long-term contracts, which are not workable due to price fluctuations.
  • The fertilizer and chemical order books for the next 3-4 weeks remain firm and healthy with consistent booking practices.

Key Metrics

Frequently Asked Questions

What were Shree Pushkar Chemicals & Fertilizers Ltd Q3 FY25 results?

FY25 revenue expected to exceed Rs. Revenue growth target for FY26 is around 25%, aiming for approximately Rs.

What is Shree Pushkar Chemicals & Fertilizers Ltd share price analysis?

Shree Pushkar Chemicals & Fertilizers Ltd currently shows a neutral. The stock trades at a P/E of 17.2 with a market cap of ₹1,243 Cr. Investors should review the full earnings analysis for detailed insights.

Is Shree Pushkar Chemicals & Fertilizers Ltd planning capital expenditure?

The company has invested Rs.

Keep Shree Pushkar Chemicals & Fertilizers Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Chemicals & Petrochemicals this season

  • Tata Chemicals (Q3 FY25)

    . Key concall takeaways from Tata Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Archean Chemical (Q3 FY25)

    . Key concall takeaways from Archean Chemical Industries Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Aether Industries Ltd (Q3 FY25)

    Site 3+ and 3++ expansion underway with potential revenue of INR 300 crores combined. Key concall takeaways from Aether Industries Ltd's Q3 FY25 earnings call…

  • Tatva Chintan (Q3 FY25)

    Revenue potential could surpass INR 900 crores with existing and upcoming capacities by 2026. Key concall takeaways from Tatva Chintan Pharma Chem Ltd's Q3…